Pharmaceutical Manufacturing Batch Record Review -Webinar by GlobalCompliancePanel 2010

The FDA and its European counterpart, EMA, require drug manufacturers to have written procedures in place to document production and process controls, better known as batch records. Additionally, there must be written procedures for a batch record review process that demonstrate compliance. An efficient and effective batch record review process provides pharmaceutical companies with two strategies. First, this effort is key to maintaining control of your firm`s manufacturing operations, eliminating any guesswork and aiding in the resolution of atypical occurrences. And, it enables a company s to maintain and demonstrate a compliant posture, a sure way to avoid any quandary with regulatory agencies. Certain elements, practices and procedures are crucial to such an efficient and effective review process. As well, such logistics can only be put in place through an proactive training regime and review management system. This webinar will analyze each of these necessary elements of the batch record review process.

Why you should attend: The Learning Objectives of this presentation include:

• Recognize regulatory (FDA/EU) requirements for batch records and batch record review
  
• Modeling best practices of a technical review of batch records
  
• Discover the essentials of batch record reviewer qualifications and training
  
• Acquire confidence in determining the final decision or recommendations.
  
• Establish a working relationship between production and quality reviewers
  
• What to do when a batch fails to meet specifications (discrepancies)